user

Efficacy and Safety of Tenapanor on Hyperphosphatemia in Japanese Hemodialysis Patients: Results of a Randomized Phase 3 Trial

被引：0
|
作者：
Fukagawa, Masafumi [1 ]
Ikejiri, Kazuaki [2 ]
Kinoshita, Jun [2 ]
Nakanishi, Kaoru [2 ]
Akizawa, Tadao [3 ]
机构：
[1] Tokai Univ, Sch Med, Isehara, Kanagawa, Japan
[2] Kyowa Kirin Co Ltd, Tokyo, Japan
[3] Showa Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO160
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial
    Block, Geoffrey A.
    Rosenbaum, David P.
    Yan, Andrew
    Chertow, Glenn M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (04): : 641 - 652
  • [2] Efficacy and Safety of Tenapanor Added to Phosphate Binders for Hemodialysis Patients Who Have Poorly Controlled Hyperphosphatemia on Existing Phosphate Binders: Results of a Randomized Phase 3 Trial
    Kazama, Junichiro J.
    Kusakabe, Miho
    Kinoshita, Jun
    Nakanishi, Kaoru
    Fukagawa, Masafumi
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 94 - 94
  • [3] Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen
    Fukagawa, Masafumi
    Urano, Natsuki
    Ikejiri, Kazuaki
    Kinoshita, Jun
    Nakanishi, Kaoru
    Akizawa, Tadao
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 82 (05) : 635 - 637
  • [4] Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial
    Masaaki Nakayama
    Shuhei Kobayashi
    Miho Kusakabe
    Meiko Ohara
    Kaoru Nakanishi
    Tadao Akizawa
    Masafumi Fukagawa
    Clinical and Experimental Nephrology, 2024, 28 : 153 - 164
  • [5] Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial
    Nakayama, Masaaki
    Kobayashi, Shuhei
    Kusakabe, Miho
    Ohara, Meiko
    Nakanishi, Kaoru
    Akizawa, Tadao
    Fukagawa, Masafumi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (02) : 153 - 164
  • [6] Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial
    Inaba, Masaaki
    Une, Yotaro
    Ikejiri, Kazuaki
    Kanda, Hironori
    Fukagawa, Masafumi
    Akizawa, Tadao
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (02): : 177 - 188
  • [7] The efficacy and safety of niacin on hyperphosphatemia in ESRD patients undergoing hemodialysis: randomized controlled trial
    Ahmed, Hanan Mahmoud
    Yossif, Esraa
    Abd-Elkader, Alaa S.
    Abdel Aziz, Essam M.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01):
  • [8] The efficacy and safety of niacin on hyperphosphatemia in ESRD patients undergoing hemodialysis: randomized controlled trial
    Hanan Mahmoud Ahmed
    Esraa Yossif
    Alaa S. Abd-Elkader
    Essam M. Abdel Aziz
    The Egyptian Journal of Internal Medicine, 2022, 34
  • [9] In Reply to "Letter Regarding 'DoseResponse of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial'"
    Inaba, Masaaki
    Une, Yotaro
    Ikejiri, Kazuaki
    Kanda, Hironori
    Fukagawa, Masafumi
    Akizawa, Tadao
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 1725 - 1726
  • [10] Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: A systematic review and meta-analysis of randomized placebo-controlled trials
    Luo, Houli
    Feng, Jian
    Zhang, Yanbiao
    Wang, Jie
    Xue, Gang
    Huang, Xi
    You, Shuang
    Dong, Hongfei
    Li, Lingfan
    Li, Juncheng
    Xiao, Hualin
    Ai, Xiang
    Li, Xianhui
    Huang, Bo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (05) : 839 - 847
12345